Angiotensin II increases mRNA levels of all TGF‐β isoforms in quiescent and activated rat hepatic stellate cells
暂无分享,去创建一个
M. Macías-Silva | J. Pedraza-Chaverri | C. González-Espinosa | E. Molina-Jijón | M. Briones-Orta | J. Medina-Tamayo | Marcela Sosa-Garrocho | Paola Moreno-Álvarez | E. Molina-jijon | Marco A. Briones‐Orta | E. Molina‐Jijón | Marcela Sosa‐Garrocho
[1] J. Pedraza-Chaverri,et al. Heme oxygenase-1 induction prevents neuronal damage triggered during mitochondrial inhibition: role of CO and bilirubin. , 2009, The international journal of biochemistry & cell biology.
[2] K. Griendling,et al. NADPH oxidases and angiotensin II receptor signaling , 2009, Molecular and Cellular Endocrinology.
[3] Araceli Arellano-Plancarte,et al. Angiotensin II and the development of insulin resistance: Implications for diabetes , 2009, Molecular and Cellular Endocrinology.
[4] R. Bataller,et al. Cytokines and renin-angiotensin system signaling in hepatic fibrosis. , 2008, Clinics in liver disease.
[5] S. Friedman. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.
[6] Peter W Angus,et al. Liver fibrosis: a balance of ACEs? , 2007, Clinical science.
[7] D. Brenner,et al. NOX in liver fibrosis. , 2007, Archives of biochemistry and biophysics.
[8] K. Griendling,et al. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. , 2007, American journal of physiology. Cell physiology.
[9] K. Krause,et al. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.
[10] Y. Murawaki,et al. Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats , 2006, Journal of Gastroenterology.
[11] J. Sicklick,et al. Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice , 2006, Hepatology.
[12] F Verrecchia,et al. [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.
[13] D. Brenner,et al. NADPH oxidase in the liver: defensive, offensive, or fibrogenic? , 2006, Gastroenterology.
[14] K. Suda,et al. Expression of Transforming Growth Factor β1, β2, and β3 in Chronic, Cancer-Associated, Obstructive Pancreatitis , 2006 .
[15] R Weiskirchen,et al. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets , 2006, Journal of cellular and molecular medicine.
[16] K. Suda,et al. Expression of transforming growth factor beta1, beta2, and beta3 in chronic, cancer-associated, obstructive pancreatitis. , 2006, Archives of pathology & laboratory medicine.
[17] M. Czaja. Another way for NADPH oxidase to send a signal for liver injury. , 2005, Gastroenterology.
[18] S. Ledbetter,et al. The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. , 2005, Journal of the American College of Surgeons.
[19] Junitsu Ito,et al. NAD(P)H oxidase plays a crucial role in PDGF‐induced proliferation of hepatic stellate cells , 2005, Hepatology.
[20] S. Sherlock,et al. Renal hemodynamics and the renin-angiotensin system in cirrhosis , 2005, Digestive Diseases and Sciences.
[21] Jonathan M. Yingling,et al. Development of TGF-β signalling inhibitors for cancer therapy , 2004, Nature Reviews Drug Discovery.
[22] B. H. Shah,et al. Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor. , 2004, Molecular endocrinology.
[23] H. Abboud,et al. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. , 2004, The Biochemical journal.
[24] Andrew Leask,et al. TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] 菅野 啓司. AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl4 , 2004 .
[26] J. Yingling,et al. Development of TGF-beta signalling inhibitors for cancer therapy. , 2004, Nature reviews. Drug discovery.
[27] R. Schwabe,et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. , 2003, The Journal of clinical investigation.
[28] Ling Yu,et al. TGF-β isoforms in renal fibrogenesis , 2003 .
[29] D. Brenner,et al. Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[30] Li Xu,et al. Expression of Angiotensin II Type 1 Receptor in Rat Hepatic Stellate Cells and Its Effects on Cell Growth and Collagen Production , 2003, Hormone Research in Paediatrics.
[31] J. P. Hobson,et al. Preferential Signaling and Induction of Allergy-promoting Lymphokines Upon Weak Stimulation of the High Affinity IgE Receptor on Mast Cells , 2003, The Journal of experimental medicine.
[32] D. Schuppan,et al. Hepatitis C and liver fibrosis , 2003, Cell Death and Differentiation.
[33] B. Andresen,et al. Role of EGFR Transactivation in Angiotensin II Signaling to Extracellular Regulated Kinase in Preglomerular Smooth Muscle Cells , 2003, Hypertension.
[34] R. Touyz,et al. Recent advances in angiotensin II signaling. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[35] A. Gressner,et al. Quantitative monitoring of the mRNA expression pattern of the TGF-β-isoforms (β1, β2, β3) during transdifferentiation of hepatic stellate cells using a newly developed real-time SYBR Green PCR , 2002 .
[36] E. Schleicher,et al. Angiotensin II induces human TGF-β1 promoter activation: similarity to hyperglycaemia , 2002, Diabetologia.
[37] P. Tighe,et al. Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. , 2002, American journal of physiology. Cell physiology.
[38] H. Yoshiji,et al. Angiotensin‐II type 1 receptor interaction is a major regulator for liver fibrosis development in rats , 2001, Hepatology.
[39] A. Logan,et al. Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney. , 2001, The Journal of endocrinology.
[40] J. Egido,et al. Angiotensin II and renal fibrosis. , 2001, Hypertension.
[41] F. Marra,et al. Cytokine Receptors and Signaling in Hepatic Stellate Cells , 2001, Seminars in liver disease.
[42] A Geerts,et al. History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells , 2001, Seminars in liver disease.
[43] H. Wei,et al. The expression of AT1 receptor on hepatic stellate cells in rat fibrosis induced by CCl4. , 2001, Chinese medical journal.
[44] C. Johnston,et al. Angiotensin receptors: distribution, signalling and function. , 2001, Clinical science.
[45] V. Giguère,et al. Requirement of Ras-dependent pathways for activation of the transforming growth factor beta3 promoter by estradiol. , 2001, Endocrinology.
[46] S. Ledbetter,et al. Renal fibrosis in mice treated with human recombinant transforming growth factor-beta2. , 2000, Kidney international.
[47] K. Catt,et al. International union of pharmacology. XXIII. The angiotensin II receptors. , 2000, Pharmacological reviews.
[48] T. Yamakawa,et al. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. , 2000, Endocrinology.
[49] R. Bataller,et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. , 2000, Gastroenterology.
[50] S. Friedman. Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.
[51] Shokei Kim,et al. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells. , 1999, Hypertension.
[52] A. Ooshima,et al. Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[53] D. Brenner,et al. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. , 1999, Journal of hepatology.
[54] H. Friess,et al. Transforming growth factor betas and their receptors in human liver cirrhosis , 1998, European journal of gastroenterology & hepatology.
[55] A. Roberts. Molecular and Cell Biology of TGF-β , 1998, Mineral and Electrolyte Metabolism.
[56] V. Rogiers,et al. Transforming growth factor-β gene expression in normal and fibrotic rat liver , 1997 .
[57] S. O'Kane,et al. Transforming growth factor βs and wound healing , 1997 .
[58] V. Rogiers,et al. Transforming growth factor-beta gene expression in normal and fibrotic rat liver. , 1997, Journal of hepatology.
[59] S. Kudoh,et al. Protein Kinase C, but Not Tyrosine Kinases or Ras, Plays a Critical Role in Angiotensin II-induced Activation of Raf-1 Kinase and Extracellular Signal-regulated Protein Kinases in Cardiac Myocytes* , 1996, The Journal of Biological Chemistry.
[60] P. Hoodless,et al. MADR2 Is a Substrate of the TGFβ Receptor and Its Phosphorylation Is Required for Nuclear Accumulation and Signaling , 1996, Cell.
[61] V. Bindokas,et al. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[62] M. Sporn,et al. Identification of an activating transcription factor (ATF) binding site in the human transforming growth factor-beta 2 promoter. , 1992, The Journal of biological chemistry.
[63] M. Sporn,et al. Structural and functional characterization of the transforming growth factor beta 3 promoter. A cAMP-responsive element regulates basal and induced transcription. , 1990, The Journal of biological chemistry.
[64] M. Macías-Silva,et al. Angiotensin II stimulates phosphoinositide turnover and phosphorylase through AII-1 receptors in isolated rat hepatocytes. , 1990, Biochemical and biophysical research communications.
[65] M. Sporn,et al. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex , 1990, Molecular and cellular biology.
[66] L. Madisen,et al. Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2 , 1989, Molecular and cellular biology.
[67] M. Sporn,et al. Activation of the second promoter of the transforming growth factor-beta 1 gene by transforming growth factor-beta 1 and phorbol ester occurs through the same target sequences. , 1989, The Journal of biological chemistry.
[68] F. Bianchi,et al. Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.
[69] S. Friedman,et al. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. , 1987, Analytical biochemistry.
[70] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[71] V. Arroyo,et al. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis , 1980 .